Prenatal maternal immune activation and brain development with relevance to psychiatric disorders

Neuroscience

Volumn 346, Issue , 2017, Pages 403-408

  Scola, Gustavo ^a   Duong, Angela ^b  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

autism; bipolar disorder; brain development; inflammation; maternal immune activation; schizophrenia

Indexed keywords

CYTOKINE;

ARTICLE; BEHAVIOR ASSESSMENT; BRAIN DEVELOPMENT; BRAIN LEVEL; CYTOKINE PRODUCTION; DATA ANALYSIS; DISEASE ASSOCIATION; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOMODULATION; MATERNAL BEHAVIOR; MATERNAL EXPOSURE; MATERNAL IMMUNE ACTIVATION; MENTAL DISEASE; OUTCOME ASSESSMENT; PRENATAL CARE; PRENATAL PERIOD; RISK ASSESSMENT; RISK FACTOR; ANIMAL; BRAIN; EMBRYOLOGY; FEMALE; FETOMATERNAL TRANSFUSION; IMMUNOLOGY; PREGNANCY; PREGNANCY COMPLICATION; PRENATAL EXPOSURE; PSYCHOLOGY;

ANIMALS; BRAIN; FEMALE; HUMANS; MATERNAL-FETAL EXCHANGE; MENTAL DISORDERS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 85012993346     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2017.01.033     Document Type: Article

References (59)

1. Allswede, D.M., Buka, S.L., Yolken, R.H., Torrey, E.F., Cannon, T.D., Elevated maternal cytokine levels at birth and risk for psychosis in adult offspring. Schizophr Res 172 (2016), 41–45.
2. Arango Duque, G., Descoteaux, A., Macrophage cytokines: involvement in immunity and infectious diseases. Front Immunol, 5, 2014, 491.
3. Atladóttir, H.O., Thorsen, P., Østergaard, L., Schendel, D.E., Lemcke, S., Abdallah, M., Parner, E.T., Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders. J Autism Dev Disord 40 (2010), 1423–1430.
4. Atladóttir, H., Henriksen, T.B., Schendel, D.E., Parner, E.T., Autism after infection, febrile episodes, and antibiotic use during pregnancy: an exploratory study. Pediatrics 130 (2012), e1447–1454.
5. Baharnoori, M., Bhardwaj, S.K., Srivastava, L.K., Effect of maternal lipopolysaccharide administration on the development of dopaminergic receptors and transporter in the rat offspring. PLoS One, 8, 2013, e54439.
6. Bale, T.L., Baram, T.Z., Brown, A.S., Goldstein, J.M., Insel, T.R., McCarthy, M.M., Nemeroff, C.B., Reyes, T.M., Simerly, R.B., Susser, E.S., Nestler, E.J., Early life programming and neurodevelopmental disorders. Biol Psychiatry 68 (2010), 314–319.
7. Bauer, S., Kerr, B.J., Patterson, P.H., The neuropoietic cytokine family in development, plasticity, disease and injury. Nat Rev Neurosci 8 (2007), 221–232.
8. Brown, A.S., Derkits, E.J., Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am J Psychiatry 167 (2010), 261–280.
9. Brown, A.S., Hooton, J., Schaefer, C.A., Zhang, H., Petkova, E., Babulas, V., Perrin, M., Gorman, J.M., Susser, E.S., Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring. Am J Psychiatry 161 (2004), 889–895.
10. Canetta, S., Bolkan, S., Padilla-Coreano, N., Song, L.J., Sahn, R., Harrison, N.L., Gordon, J.A., Brown, A., Kellendonk, C., Maternal immune activation leads to selective functional deficits in offspring parvalbumin interneurons. Mol Psychiatry 21 (2016), 956–968.
11. Cassella, S.N., Hemmerle, A.M., Lundgren, K.H., Kyser, T.L., Ahlbrand, R., Bronson, S.L., Richtand, N.M., Seroogy, K.B., Maternal immune activation alters glutamic acid decarboxylase-67 expression in the brains of adult rat offspring. Schizophr Res 171 (2016), 195–199.
12. Coiro, P., Padmashri, R., Suresh, A., Spartz, E., Pendyala, G., Chou, S., Jung, Y., Meays, B., Roy, S., Gautam, N., Alnouti, Y., Li, M., Dunaevsky, A., Impaired synaptic development in a maternal immune activation mouse model of neurodevelopmental disorders. Brain Behav Immun 50 (2015), 249–258.
13. Crampton, S.J., Collins, L.M., Toulouse, A., Nolan, Y.M., O'Keeffe, G.W., Exposure of fetal neural progenitor cells to IL-1β impairs their proliferation and alters their differentiation – a role for maternal inflammation?. J Neurochem 120 (2012), 964–973.
14. Dantzer, R., O'Connor, J.C., Freund, G.G., Johnson, R.W., Kelley, K.W., From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9 (2008), 46–56.
15. Davies, G., Welham, J., Chant, D., Torrey, E.F., McGrath, J., A systematic review and meta-analysis of Northern Hemisphere season of birth studies in schizophrenia. Schizophr Bull 29 (2003), 587–593.
16. Depino, A.M., Early prenatal exposure to LPS results in anxiety- and depression-related behaviors in adulthood. Neuroscience 299 (2015), 56–65.
17. Estes, M.L., McAllister, A.K., Immune mediators in the brain and peripheral tissues in autism spectrum disorder. Nat Rev Neurosci 16 (2015), 469–486.
18. Fatemi, S.H., Emamian, E.S., Sidwell, R.W., Kist, D.A., Stary, J.M., Earle, J.A., Thuras, P., Human influenza viral infection in utero alters glial fibrillary acidic protein immunoreactivity in the developing brains of neonatal mice. Mol Psychiatry 7:6 (2002), 633–640 PMID: 12140787.
19. Felger, J.C., Lotrich, F.E., Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications. Neuroscience 246 (2013), 199–229.
20. Fillman, S.G., Cloonan, N., Catts, V.S., Miller, L.C., Wong, J., McCrossin, T., Cairns, M., Weickert, C.S., Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia. Mol Psychiatry 18 (2013), 206–214.
21. Fillman, S.G., Weickert, T.W., Lenroot, R.K., Catts, S.V., Bruggemann, J.M., Catts, V.S., Weickert, C.S., Elevated peripheral cytokines characterize a subgroup of people with schizophrenia displaying poor verbal fluency and reduced Broca's area volume. Mol Psychiatry 21 (2016), 1090–1098.
22. Garay, P.A., Hsiao, E.Y., Patterson, P.H., McAllister, A.K., Maternal immune activation causes age- and region-specific changes in brain cytokines in offspring throughout development. Brain Behav Immun 31 (2013), 54–68.
23. Giovanoli, S., Weber, L., Meyer, U., Single and combined effects of prenatal immune activation and peripubertal stress on parvalbumin and reelin expression in the hippocampal formation. Brain Behav Immun 40 (2014), 48–54.
24. Goldsmith, D.R., Rapaport, M.H., Miller, B.J., A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder, and depression. Mol Psychiatry 21 (2016), 1696–1709.
25. Gorrini, C., Harris, I.S., Mak, T.W., Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discov 12 (2013), 931–947.
26. Jiang, H.Y., Xu, L.L., Shao, L., Xia, R.M., Yu, Z.H., Ling, Z.X., Yang, F., Deng, M., Ruan, B., Maternal infection during pregnancy and risk of autism spectrum disorders: a systematic review and meta-analysis. Brain Behav Immun 58 (2016), 165–172.
27. Kent, A.S., Sullivan, M.H., Elder, M.G., Transfer of cytokines through human fetal membranes. J Reprod Fertil 100 (1994), 81–84.
28. Knuesel, I., Chicha, L., Britschgi, M., Schobel, S.A., Bodmer, M., Hellings, J.A., Toovey, S., Prinssen, E.P., Maternal immune activation and abnormal brain development across CNS disorders. Nat Rev Neurol 10 (2014), 643–660.
29. Konrath, L., Beckius, D., Tran, U.S., Season of birth and population schizotypy: results from a large sample of the adult general population. Psychiatry Res 242 (2016), 245–250.
30. Li, X., Chauhan, A., Sheikh, A.M., Patil, S., Chauhan, V., Li, X.M., Ji, L., Brown, T., Malik, M., Elevated immune response in the brain of autistic patients. J Neuroimmunol 207 (2009), 111–116.
31. Luchicchi, A., Lecca, S., Melis, M., De Felice, M., Cadeddu, F., Frau, R., Muntoni, A.L., Fadda, P., Devoto, P., Pistis, M., Maternal immune activation disrupts dopamine system in the offspring. Int J Neuropsychopharmacol, 19, 2016, 7.
32. Masi, A., Quintana, D.S., Glozier, N., Lloyd, A.R., Hickie, I.B., Guastella, A.J., Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis. Mol Psychiatry 20 (2015), 440–446.
33. Meyer, U., Prenatal poly(i:C) exposure and other developmental immune activation models in rodent systems. Biol Psychiatry 75 (2014), 307–315.
34. Miller, A.H., Raison, C.L., The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol 16 (2016), 22–34.
35. Miller, B.J., Buckley, P., Seabolt, W., Mellor, A., Kirkpatrick, B., Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry 70 (2011), 663–671.
36. Modabbernia, A., Taslimi, S., Brietzke, E., Ashrafi, M., Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies. Biol Psychiatry 74 (2013), 15–25.
37. Mortensen, P.B., Pedersen, C.B., Hougaard, D.M., Nørgaard-Petersen, B., Mors, O., Børglum, A.D., Yolken, R.H., A Danish National Birth Cohort study of maternal HSV-2 antibodies as a risk factor for schizophrenia in their offspring. Schizophr Res 122 (2010), 257–263.
38. Mousa, A., Bakhiet, M., Role of cytokine signaling during nervous system development. Int J Mol Sci 14 (2013), 13931–13957.
39. Parboosing, R., Bao, Y., Shen, L., Schaefer, C.A., Brown, A.S., Gestational influenza and bipolar disorder in adult offspring. JAMA Psychiatry 70 (2013), 677–685.
40. Patrich, E., Piontkewitz, Y., Peretz, A., Weiner, I., Attali, B., Maternal immune activation produces neonatal excitability defects in offspring hippocampal neurons from pregnant rats treated with poly I:C. Sci Rep, 6, 2016, 19106.
41. Piontkewitz, Y., Arad, M., Weiner, I., Abnormal trajectories of neurodevelopment and behavior following in utero insult in the rat. Biol Psychiatry 70 (2011), 842–851.
42. Ploeger, A., Raijmakers, M.E., van der Maas, H.L., Galis, F., The association between autism and errors in early embryogenesis: what is the causal mechanism?. Biol Psychiatry 67 (2010), 602–607.
43. Rao, J.S., Harry, G.J., Rapoport, S.I., Kim, H.W., Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients. Mol Psychiatry 15:4 (2010), 384–392, 10.1038/mp.2009.47 Epub 2009 Jun 2, PMID: 19488045.
44. Rao, J.S., Kim, H.W., Harry, G.J., Rapoport, S.I., Reese, E.A., Increased neuroinflammatory and arachidonic acid cascade markers, and reduced synaptic proteins, in the postmortem frontal cortex from schizophrenia patients. Schizophr Res 147 (2013), 24–31.
45. Richetto, J., Calabrese, F., Riva, M.A., Meyer, U., Prenatal immune activation induces maturation-dependent alterations in the prefrontal GABAergic transcriptome. Schizophr Bull 40 (2014), 351–361.
46. Saunders, N.R., Liddelow, S.A., Dziegielewska, K.M., Barrier mechanisms in the developing brain. Front Pharmacol, 3, 2012, 46.
47. Shi, L., Smith, S.E., Malkova, N., Tse, D., Su, Y., Patterson, P.H., Activation of the maternal immune system alters cerebellar development in the offspring. Brain Behav Immun 23 (2009), 116–123.
48. Smith, S.E., Li, J., Garbett, K., Mirnics, K., Patterson, P.H., Maternal immune activation alters fetal brain development through interleukin-6. J Neurosci 27 (2007), 10695–10702.
49. Sullivan, P.F., Daly, M.J., O'Donovan, M., Genetic architectures of psychiatric disorders: the emerging picture and its implications. Nat Rev Genet 13 (2012), 537–551.
50. Torrey, E.F., Rawlings, R.R., Ennis, J.M., Merrill, D.D., Flores, D.S., Birth seasonality in bipolar disorder, schizophrenia, schizoaffective disorder and stillbirths. Schizophr Res 21 (1996), 141–149.
51. Toyooka, K., Watanabe, Y., Iritani, S., Shimizu, E., Iyo, M., Nakamura, R., Asama, K., Makifuchi, T., Kakita, A., Takahashi, H., Someya, T., Nawa, H., A decrease in interleukin-1 receptor antagonist expression in the prefrontal cortex of schizophrenic patients. Neurosci Res 46 (2003), 299–307.
52. Urakubo, A., Jarskog, L.F., Lieberman, J.A., Gilmore, J.H., Prenatal exposure to maternal infection alters cytokine expression in the placenta, amniotic fluid, and fetal brain. Schizophr Res 47 (2001), 27–36.
53. Wei, H., Zou, H., Sheikh, A.M., Malik, M., Dobkin, C., Brown, W.T., Li, X., IL-6 is increased in the cerebellum of autistic brain and alters neural cell adhesion, migration and synaptic formation. J Neuroinflammation, 8, 2011, 52.
54. Wischhof, L., Irrsack, E., Dietz, F., Koch, M., Maternal lipopolysaccharide treatment differentially affects 5-HT(2A) and mGlu2/3 receptor function in the adult male and female rat offspring. Neuropharmacology 97 (2015), 275–288.
55. Yarlagadda, A., Alfson, E., Clayton, A.H., The blood brain barrier and the role of cytokines in neuropsychiatry. Psychiatry (Edgmont) 6 (2009), 18–22.
56. Zalcman, S., Green-Johnson, J.M., Murray, L., Nance, D.M., Dyck, D., Anisman, H., Greenberg, A.H., Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6. Brain Res 643 (1994), 40–49.
57. Zaretsky, M.V., Alexander, J.M., Byrd, W., Bawdon, R.E., Transfer of inflammatory cytokines across the placenta. Obstet Gynecol 103 (2004), 546–550.
58. Zerbo, O., Iosif, A.M., Delwiche, L., Walker, C., Hertz-Picciotto, I., Month of conception and risk of autism. Epidemiology 22 (2011), 469–475.
59. Zerbo, O., Iosif, A.M., Walker, C., Ozonoff, S., Hansen, R.L., Hertz-Picciotto, I., Is maternal influenza or fever during pregnancy associated with autism or developmental delays? Results from the CHARGE (CHildhood Autism Risks from Genetics and Environment) study. J Autism Dev Disord 43 (2013), 25–33.